Sansone, A. http://orcid.org/0000-0002-1210-2843
Reisman, Y. http://orcid.org/0000-0002-1513-6360
Jannini, E. A. http://orcid.org/0000-0002-5874-039X
Funding for this research was provided by:
Menarini International Operations Luxembourg S.A
Article History
Received: 16 October 2021
Accepted: 1 December 2021
First Online: 8 January 2022
Declarations
:
: The funder had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. EAJ has been speaker and/or paid consultant for Bayer, Ibsa, Lundbeck, Menarini, Otsuka, Pfizer, Shionogi, and Viatris. YR has been speaker and/or consultant for Lundbeck, Pfizer, Boston, Ibsa, and Besins. AS has no conflict of interests to declare.
: No approval needed.
: No patients were involved in the present research.
: All authors give consent for publication.
: Emmanuele A. Jannini is an Editor for the Journal of Endocrinological Investigation. Andrea Sansone has been invited in November 2021 to join the Editorial Board.
Free to read: This content has been made available to all.